Consulting Services for Clinical Trials
In this 30-minute webinar, Dr. Luca Pani, VP Regulatory Strategy and Market Access Innovation, leads a panel discussion around value endpoints and to discuss the need to demonstrate pharmacoeconomic value earlier in the development process.
The reimbursement environment is ever evolving. To help you optimize your market access objectives, our in-house team of experts, led by Dr. Luca Pani, have hands-on experience with innovative health economics and outcomes research (HEOR) across many different therapeutic areas.
VeraSci will work with you early in your program to identify the value brought to patients, providers, and payers by using the most advanced market access strategies and health economics models. We will partner with you to design studies that generate the most relevant data on hand to demonstrate the value of your innovations.
Our HEOR Services:
- Value-based strategic pricing models
- Payer strategic consulting, including mock negotiation
- Market access strategy development
- Value Endpoint Trial Design and Implementation
- HTA & Evidence reviews
Our HEOR team will develop the strategic path and identify “value endpoints” that achieve your reimbursement goals.
Scientific Consulting & Regulatory Guidance
From protocol design and endpoint selection to statistical analysis, our scientific and regulatory teams adopt a supportive and collaborative approach to providing proactive and prospective advice to our clients and sponsors.
Engage our team to advise on:
- Regulatory and protocol guidance
- Endpoint selection and test development
- Clinical trial design
- Biostatistical analysis
- Regulatory agency response communications